Stocks · Health care · Pharmaceutical Preparations

Bicara Therapeutics Inc.

BCAX Clue Score37

United States Fiscal year ends December CIK 0002023658 Results filed 11 Aug 2026

Add to watchlist

By person

6 insiders · 64 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$4.80M (1)

—

+$4.80M

4,603,418

6.96%

$107.88M

+7.0%

Ryan Cohlhepp

President, COO & Interim CEO

—

$3.46M (23) scheduled

−$3.46M

181,641

0.2745%

$4.26M

−17.9%

Claire Mazumdar

Chief Executive Officer

—

$3.14M (14) scheduled

−$3.14M

362,152

0.5473%

$8.49M

+16.9%

Ivan Hyep

Chief Financial Officer

—

$2.57M (13) scheduled

−$2.57M

129,855

0.1962%

$3.04M

−10.7%

David Raben

Chief Medical Officer

—

$740.78K (7) scheduled

−$740.78K

55,286

0.0835%

$1.30M

+55.7%

Lara Meisner

Chief Legal Officer

—

0.0000%

$0.00

—

Bicara Therapeutics Inc.

What the insiders did Net buying

By person